PEGylation - 21 News

Tip: You can further refine your news selection by departments, organizations, countries and industries.

PEGylation - 21 News

Tip: You can further refine your news selection by departments, organizations, countries and industries.

image description

Tethered nanoparticles make tumor cells more vulnerable

22-Mar-2017 - MIT researchers have devised a way to make tumor cells more susceptible to certain types of cancer treatment by coating the cells with nanoparticles before delivering drugs. By tethering hundreds of tiny particles to the surfaces of tumor cells in the presence of a mechanical force, the ...

PEGylation apoptosis biodegradable polymers
image description

Direct radiolabeling of nanomaterials

10-Feb-2017 - Positron emission tomography plays a pivotal role for monitoring the distribution and accumulation of radiolabeled nanomaterials in living subjects. The radioactive metals are usually connected to the nanomaterial through an anchor, a so-called chelator, but this chemical binding can be omitted ...

PEGylation bioimaging copper
image description

Drug delivery modification sidesteps allergic responses

02-Dec-2016 - Biomedical engineers at Duke University have reconfigured a popular drug-delivery technology to evade immune responses that have halted some clinical trials. Polyethylene glycol, commonly known as PEG, is a polymer commonly found in commercial products from toothpaste to cosmetics, and also in ...

PEGylation antibodies bloodstream
image description

Stealth effect of nanocarriers for drug delivery vehicles conferred more efficiently

17-Feb-2016 - Scientists of the University Medical Center of the Johannes Gutenberg University Mainz and of the Max Planck Institute for Polymer Research (MPI-P) decipher stealth effect of nanocarriers evading clearance by the immune system. By using drug delivery vehicles, so-called nanocarriers, ...

PEGylation drug delivery nanocarriers

celares GmbH establishes collaboration with NOF

14-Nov-2012 - NOF CORPORATION and celares GmbH, Germany have established strategic collaboration in the field of PEGylation. The collaboration will enable NOF CORPORATION to strengthen its position in an increasingly competitive market for Activated PEG supply. Collaboration of celares with NOF means a ...

PEGylation

PolyTherics is granted a further patent for its TheraPEG PEGylation technology

09-Jun-2011 - PolyTherics Limited announced that a further patent has been issued by the US Patent Office for TheraPEG™, PolyTherics’ proprietary method of improving the pharmacokinetic properties of proteins and peptides. The patent consolidates PolyTherics’ TheraPEG™ patent portfolio, which covers proteins ...

PEGylation patents peptides

celares GmbH brings GMP-production facility into operation

11-Oct-2010 - The Berlin drug delivery company celares GmbH has brought a GMP production facility for the synthesis of activated PEG-reagents into operation in September. The company now belongs to a handful of worldwide suppliers that is capable of producing these special reagents in the required quality for ...

PEGylation chemical synthesis clean-rooms

PolyTherics to collaborate with UCL to develop a new treatment for ‘sticky blood’ syndrome

29-Sep-2010 - PolyTherics Limited announced a new collaboration with Professor Anisur Rahman at UCL (University College London), to use its proprietary site-specific PEGylation to develop a treatment for antiphospholipid syndrome. Professor Rahman and his team have been awarded a 5-year grant of nearly ...

PEGylation antibodies anticoagulants

PolyTherics moves lead candidate into development and manufacturing with DSM BioSolutions

09-Sep-2010 - DSM BioSolutions, DSM’s microbial fermentation CMO business unit and PolyTherics Limited announced that they have entered into an agreement for the process development and manufacture of PolyTherics’ lead biobetter product, HiPEG™ IFN alpha-2a. PolyTherics has applied its HiPEG™ site-specific ...

PEGylation fermentation hepatitis C

PolyTherics Initiates New Research and Option Agreement with Top Ten Pharmaceutical Company

29-Apr-2010 - PolyTherics Limited announced a research and option agreement with one of the world’s top ten pharmaceutical companies. PolyTherics will apply its proprietary drug modification technologies to a target protein of commercial interest to its collaborator. The study will utilise PolyTherics’ ...

PEGylation antibody fragments biologics
Search all
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 27,310 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now